« Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring » (2026) Canadian Diabetes & Endocrinology Today, 4(1), p. 10–16. doi:10.58931/cdet.2026.4150.